59
Participants
Start Date
October 31, 2012
Primary Completion Date
February 28, 2015
Study Completion Date
February 28, 2015
Non-coumadin Oral Anticoagulant
Administration of Non-coumadin Oral Anticoagulant for 30 days following episode of atrial fibrillation as detected by the Reveal XT device.
Northwestern University, Chicago
Beth Israel Deaconess Medical Center, Boston
University of Western Ontario, London
Collaborators (1)
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Medtronic
INDUSTRY
Northwestern University
OTHER